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Abstract
Background: The successful cure of tuberculosis (TB) is dependent on adherence to treatment. Various factors
influence adherence, however, few are easily modifiable. There are limited data regarding correlates of psychological
distress and their association with non-adherence to anti-TB treatment.
Methods: In a trial of a new TB test, we measured psychological distress (K-10 score), TB-related health literacy, and
morbidity (TBscore), prior to diagnosis in 1502 patients with symptoms of pulmonary TB recruited from clinics in
Cape Town (n = 419), Harare (n = 400), Lusaka (n = 400), Durban (n = 200), and Mbeya (n = 83). Socioeconomic,
demographic, and alcohol usage-related data were captured. Patients initiated on treatment had their DOTS cards
reviewed at two-and six-months.
Results: 22 %(95 % CI: 20 %, 25 %) of patients had severe psychological distress (K-10 ≥ 30). In a multivariable linear
regression model, increased K-10 score was independently associated with previous TB [estimate (95 % CI) 0.98(0.09-1.87);
p = 0.0304], increased TBscore [1(0.80, 1.20); p <0.0001], and heavy alcohol use [3.08(1.26, 4.91); p = 0.0010], whereas male
gender was protective [-1.47(−2.28, −0.62); p = 0.0007]. 26 % (95 % CI: 21 %, 32 %) of 261 patients with culture-confirmed
TB were non-adherent. In a multivariable logistic regression model for non-adherence, reduced TBscore [OR (95 % CI)
0.639 (0.497, 0.797); p = 0.0001], health literacy score [0.798(0.696, 0.906); p = 0.0008], and increased K-10 [1.082(1.033,
1.137); p = 0.0012], and heavy alcohol usage [14.83(2.083, 122.9); p = 0.0002], were independently associated.
Culture-positive patients with a K-10 score ≥ 30 were more-likely to be non-adherent (OR = 2.290(1.033-5.126);
p = 0.0416].
Conclusion: Severe psychological distress is frequent amongst TB patients in Southern Africa. Targeted
interventions to alleviate psychological distress, alcohol use, and improve health literacy in newly-diagnosed TB
patients could reduce non-adherence to treatment.
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Background
Tuberculosis (TB) is a preventable and curable disease,
yet it is responsible for over 1.3 million deaths every year
[1]. Patients with TB are treated for six to nine months
with antibiotics. Although heavy alcohol use and smok-
ing are independently associated with an increased risk
of TB infection [2–7], screening, care and counselling
for these conditions, as well as care for psychiatric
illness, is poorly integrated with TB care, and is infre-
quently available to patients attending clinics in high
burden, resource-limited settings.
Adherence to anti-TB treatment can widely vary, with
some studies reporting rates of default of up to 50 %
[8]. A broad range of patient-specific demographic,
financial, and behavioural factors, as well setting-and
regimen-specific factors are known to influence adher-
ence [9, 10], however, most of these, such as household
income, are not easily alterable by healthcare providers.
Furthermore, TB patients are known to consider
defaulting several times over the course of treatment,
with the intensity of their motivation to complete their
regimen fluctuating [11, 12]. Those who default are,
compared to patients who are adherent, at increased
risk of morbidity and mortality, are more likely to de-
velop drug resistance, and are more likely to transmit
TB.
A high prevalence of psychological distress (including
symptoms depression and anxiety) has been documented
amongst TB patients. One South African study found
60 % of patients to have symptoms of depression [13].
Another found 33 % of patients to have symptoms of
severe psychological distress [14], and another demon-
strated a trend of increased adverse life events associated
with increased TB incidence [15]. The Kessler K-10
questionnaire, which has been validated in a variety of
settings as part of population-level mental health surveys
[16], is a tool for population-level screening of people
who are likely to meet formal DSM-IV definitions for
anxiety or depressive disorders, and those who have sub-
clinical psychiatric illness [17]; yet the K-10 question-
naire has not been widely used to study the interaction
between mental health and infectious diseases.
Psychological distress, which is known to down-
regulate the immune response [18], may, in addition to
making patients less likely to seek care, influence anti-
TB treatment adherence and clinical outcome (e.g.,
culture-conversion or death) [19]. Additionally, TB pa-
tients who are psychologically distressed might congre-
gate in settings where transmission is more likely to
occur, such as homeless shelters or informal pubs or
bars, and hence might be more likely to be infected
with TB. There is, however, little known about corre-
lates of psychological distress, including socioeco-
nomic factors, in the context of TB. Finally, the linkage
between psychological distress and adverse clinical
events, such as treatment non-adherence, is poorly
studied.
We did a large, five-site clinical study that examined the
effect of a new TB test in patients seeking care for TB in
primary care settings in five sites in Southern Africa [20].
Here we report on psychological distress in this cohort.
We primarily hypothesised that patients who had higher
levels of psychological distress would be more likely to be
non-adherent to their anti-TB treatment. We also
explored the association between psychological distress,
clinical characteristics (such as TB-related morbidity),
socioeconomic characterstics (such as income, educational
level, health literacy, and unemployment), and healthcare
seeking behaviour, such as the duration of symptoms that
passed before patients sought care.
Methods
Study design
We conducted a pragmatic, randomised (1:1), parallel-
arm, multi-centric trial between April 2011 and October
2012, during which patients received either Xpert MTB/
RIF [21], a new World Health Organisation-approved
test, or sputum smear microscopy for the frontline diag-
nosis of TB [20]. The trial was registered on Clinical-
trials.gov (identifier NCT01554384).
We collected clinical, psychosocial, and socioeconomic
information at recruitment, and after two months and six
months of anti-TB treatment.
Study sites and inclusion criteria
After written informed consent, we consecutively
enrolled patients ≥18 years who presented to periurban
primary-care TB clinics in Cape Town (South Africa),
Durban (South Africa), Harare (Zimbabwe), Lusaka
(Zambia), and Mbeya (Tanzania). The study was
approved by local ethics committees at each site. We
enrolled consenting patients who had symptom(s) of
pulmonary TB according to predefined WHO criteria
[22, 23], who could expectorate at least two sputum
specimens, and who had not been on anti-TB treatment
within the last 60 days.
Procedures
Patients were offered voluntary testing and counselling
for HIV at recruitment. All patients received a package
of diagnostic tests for TB (chest radiography, liquid cul-
ture, and microscopy or Xpert MTB/RIF). If a positive
bacteriological result was obtained, the patient was re-
ferred for the initiation of anti-TB treatment. Patients
who were not bacteriological test-positive for TB were
referred for routine clinical review, and could still be ini-
tiated on treatment based on clinical signs and symp-
toms at their doctor’s discretion.
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Adherence to anti-TB treatment
Nurses at each site reviewed the patients DOTS clinic
card at two month and six months after the initiation of
anti-TB treatment. Patients who were noted to have
missed at a scheduled DOTS visit were classified as non-
adherent.
Collection of psychosocial and economic data
All patients had their demographic and clinic informa-
tion captured using a validated case record form. The
Kessler K-10 questionnaire [24, 25], which measure psy-
chological distress within the last 30 days (Additional file
1: Table S1) was, together with a standardised TB health
literacy questionnaire (Additional file 1: Table S2) [26],
administered by nurses in English or the patient’s mother
tongue. TB-related morbidity was measured using the
validated TBscore symptom scoring system [27, 28]
(Additional file 1: Table S3). Information about cigarette
and alcohol consumption, educational level, personal-
and household-income were also captured. Patients
started on anti-TB treatment were followed-up at two-
and six-month post-enrolment by study staff, at which
time their TB-related morbidity was measured.
Case definitions
Patients were classified as definite TB if sputum collected
at recruitment grew acid-fast bacilli in liquid culture
(Mycobacteria Growth Indicator Tube, MGIT; BD Micro-
biology Systems, USA), which was identified as Mycobac-
terium tuberculosis complex [29].
Statistical analyses
Fisher’s exact test with mid-P correction was used for
comparisons between proportions. We developed a
series of multivariable regression models to examine in-
dependent associates of: (i) psychological distress (K-10
score); (ii) non-adherence to anti-TB treatment; (iii) im-
provement in morbidity after six months of treatment;
(iv) mortality; (v) cough duration prior to seeking care;
and (vi) whether patients reported at follow-up their
employment had been affected by their TB. We adjusted
for potential confounding, intra-site interactions, and
clustering using fixed effects. Analyses were performed
using OpenEpi (version 2.3.1) [30], Graphpad Prism
(version 6.0; GraphPad Software, USA), and R (version 3.0)
[31]. All statistical tests are two-sided at α = 0.05.
Role of the funding source
The European and Developing Countries Clinical Trials
Partnership had no role in study design, data collection,
data analysis, data interpretation, or writing of the
report. The corresponding author had full access to all
the data in the study and had final responsibility for the
decision to submit for publication.
Results
Demographic, educational, and economic characteristics
A patient flow diagram is shown in Fig. 1. We enrolled
1502 patients; the demographic, clinical, and socioeconomic
characteristics of which are summarised in Table 1. Most
patients were men (57 %), living with HIV (60 %), and had
TB for the first time (74 %). Twenty eight percent of
patients self-reported to be tobacco smokers, and 48 % said
that they did not consume alcohol. Most patients had
attained a middle school (28 %) or high school qualifica-
tion (26 %), and had a median [interquartile range (IQR)]
TB health literacy score of 6 (4–8) out of 13. Most patients
were unemployed (55 %), reported a personal income
falling within the lowest tier (43 %; <600 ZAR per month
for the South African sites or <100 US$ per month for the
others sites), and a household income falling within the
second lowest tier (39 %; 600–3000 ZAR per month for
the South African sites or 100–300 US$ per month for the
other sites). Twenty four percent of patients had culture-
confirmed TB.
Fig. 1 Study profile
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Table 1 Cohort demographic, clinical, psychosocial and economic characteristics at baseline by site
Gugulethu TB clinic










Number of patients 419 400 400 200 83 1502
Demographic and clinical information
Age [median (IQR)] 39 (31–49) 38 (32–45) 35 (30–41) 37 (30–50) 37 (31–54) 37 (30–46)
Male (%) 259 (62) 185 (46) 269 (67) 104 (52) 42 (51) 859 (57)
Previously had TB (%) 178 (43) 67 (17) 85 (21) 52 (26) 2 (1) 384 (26)
HIV-infecteda (%) 133 (32) 324 (81) 268 (67) 121 (61) 49 (59) 895 (60)
TB symptom score [TBscore; median (IQR)] 4 (3–5) 4 (3–5) 5 (4–7) 5 (4–6) 7 (4–9)
Culture-confirmed TB cases (%) 74 (18) 77 (19) 152 (38) 35 (18) 29 (35) 367 (24)
Kessler K-10 score
Median (IQR)e 20 (16–24) 30 (25–35) 16 (10–24) 18 (15–22) 29 (23–33) 22 (16–29)
Graded as severe (≥30) (%) 31/413 (8) 201/400 (50) 49/399 (12) 16/199 (8) 38/74 (51) 335 (22)
Substance use
Tobacco smoker (%) 249 (60) 32 (8) 92 (23) 48 (24) 9 (11) 430 (28)
Alcohol consumptionb (%)
Never 74 (18) 252 (63) 205 (51) 119 (60) 48 (58) 698 (47)
Social 169 (40) 86 (22) 67 (17) 49 (25) 5 (6) 376 (25)
Regular 120 (29) 60 (15) 82 (21) 18 (9) 30 (36) 310 (21)
Heavy 20 (5) 2 (1) 46 (12) 0 (0) 0 (0) 68 (5)
Educational and psychosocial characteristics
Educational levelc (%)
None 7 (2) 0 (0) 35 (9) 14 (7) 28 (34) 84 (6)
Primary school 65 (16) 95 (24) 178 (45) 30 (15) 46 (55) 414 (28)
Middle school 249 (59) 91 (23) 6 (2) 51 (26) 0 (0) 397 (26)
High School 3 (1) 17 (5) 164 (41) 44 (22) 2 (2) 230 (15)
Intermediate or post-high school diploma 20 (5) 52 (13) 17 (4) 60 (30) 7 (8) 156 (10)
Graduate or post-graduate 1 (0) 11 (3) 1 (0) 6 (3) 0 (0) 19 (1)
TB health literacy scored [median (IQR)] 7 (5–9) 5 (4–7) 7 (4–9) 7 (5–9) 2 (1–4) 6 (4–8)
Economic characteristics
Unemployed or retiredf (%) 280 (67) 257 (64) 144 (36) 88 (44) 55 (66) 824 (55)
Personal monthly incomeg (%)
Tier 1 271 (65) 222 (56) 87 (22) 22 (11) 37 (45) 639 (43)













Table 1 Cohort demographic, clinical, psychosocial and economic characteristics at baseline by site (Continued)
Tier 3 16 (4) 44 (11) 25 (6) 23 (12) 1 (1) 109 (7)
Tier 4 3 (<1) 3 (<1) 0 (0) 10 (5) 5 (6) 21 (1)
Household monthly incomeg (%)
Tier 1 209 (50) 123 (31) 87 (22) 22 (11) 38 (46) 479 (32)
Tier 2 170 (41) 165 (41) 121 (30) 98 (49) 32 (39) 586 (39)
Tier 3 28 (7) 80 (20) 26 (7) 26 (13) 1 (1) 161 (11)
Tier 4 5 (1) 31 (8) 0 (0) 11 (6) 5 (6) 52 (4)
Abbreviation: IQR, interquartile range
a18 patients (1 %) were of unknown HIV status
b50 patients (3 %) had an unknown level of alcohol consumption
c18 patients (%) had missing level of education data
d26 patients (2 %) did not have sufficient data to compute a TB health literacy score
e7 (<1 %) of patients did not have sufficient data to compute a Kessler K-10 score
f4 patients (<1 %) were missing information about their employment status
gThe monthly income tiers correspond to Under 600 ZAR, 600–3000 ZAR, 3001–7000 ZAR, and More than 7000 ZAR for the South African sites, and Under 100 US$, 100–300 US$, 301–700 US$, and More than 701 US$














Twenty two percent of patients with symptoms of pul-
monary TB (335/1502) had a severe level of psycho-
logical distress (K-10 score ≥30 [32]) and this was higher
in Harare (50 %) and Mbeya (51 %), compared to Lusaka
(12 %), Cape Town (8 %) and Durban (8 %). K-10 score
strongly positively correlated with TBscore (Spearnman’s
Rho 0.1264, p <0.0001; Fig. 2). Women had a higher level
of psychological distress than men [median (IQR) K-10
score of 24 (18–30) vs. 21 (15–27); p <0.0001]. HIV-
infected patients had a higher level of psychological dis-
tress compared to those who were HIV-uninfected [24
(17–30) vs. 20 (14.25-25.0); p <0.0001]. In a multivariate
linear regression model for psychological distress (Table 2),
female gender [estimate (95 % CI) = 1.47 (2.28, 0.62);
p = 0.0007], previous TB [estimate = 0.98 (0.09-1.87);
p = 0.0304], increased TBscore [estimate = 1 (0.80, 1.20);
p <0.0001], and heavy alcohol usage [estimate = 3.08
(1.26, 4.91); p = 0.0010], were associated with increased
K-10 score. Culture-confirmed TB was not associated
with increased K-10 score [23 (16, 29) vs. 22 (15–29) in
culture-negative patients; p = 0.2727]. In a multivariate
logistic regression model for severe psychological
distress (K-10 ≥ 30), TBscore [OR (95 % CI) = 1.30
(1.20, 1.41); p <0.0001] and site [7.96 (3.61, 18.26) for
Mbeya (p <0.0001), and 15.77 (8.81, 30.17) for Harare
(p <0.0001)] were the only independent predictors.
Anti-TB treatment adherence
Twenty six percent (69/261) of patients with confirmed
TB who were placed on treatment and followed-up at
two or six months were non-adherent. These patients
had a higher K-10 score [median (IQR) 27.0 (23–33) vs.
21.5 (16–29); p <0.0001)] and a lower level of TB-related
health literacy [5.5 (4–7) vs. 7 (4–8); p = 0.0131)] at
recruitment than those who were adherent. When multi-
variable adjustments were performed to account for site-,
baseline morbidity-, and other clinical- and socioeconomic
differences (Table 3), the significant association of K-10
score [OR = 1.082 (1.033, 1.137); p = 0.0012] and health
literacy [OR = 0.798 (0.696, 0.906); p = 0.0008] with non-
adherence persisted. TB-related morbidity at recruitment
[OR = 0.639 (0.497, 0.797); p = 0.0002] and heavy alcohol
usage [OR = 14.83 (2.083, 122.9); p = 0.0002] were also
associated with an elevated risk of treatment non-
adherence. When psychological distress was included in
the logistic regression model as a dichotomous variable,
a K-10 score ≥30 was associated with a 2.29-fold (1.033,
5.126; p = 0.0417) relative increase in the relative risk of
non-adherence (provided the other variables held constant).
Morbidity
Patients placed on treatment who had a ≥25 % improve-
ment in their morbidity score after six months had a
higher level of psychological distress at baseline than those
who did not [median (IQR) TBscore of 23 (17–28) vs. 17
(10–23); p <0.0001]. When correlates of per-patient
changes in morbidity between baseline and six months
were examined in a multivariate analysis (Table 4),
patients who were younger [estimate (95 % CI) = −0.01
(−0.02, −0.01); p = 0.0096], female [estimate = 0.26 (0.04,
0.49); p = 0.0208], had previous TB [estimate = −0.01
(−0.02, −0.01); p = 0.0096], were HIV-infected [estimate =
0.41 (0.16, 0.65); p = 0.0011], were culture-positive
[estimate = 0.59 (0.32, 0.85); p <0.0001] or who had a
higher K-10 score at recruitment [estimate = 0.41 (0.02,
0.06); p <0.0001] had the largest improvement in their
morbidity.
Mortality
Patients who started treatment and died during the six
month follow-up period had a higher level of psycho-
logical distress at recruitment compared to those that
were alive at six months [median (IQR) K-10 scores of
26.5 (20.25-33) vs. 24 (17–30); p = 0.0268]. Morbidity at
recruitment was, however, the strongest predictor of
mortality during the six month follow-up period in a
multivariate model (Additional file 1: Table S4)
[OR = 1.43 (1.28, 1.69); p <0.0001]. Older age [OR =
1.03 (1.01, 1.05); p = 0.0013], HIV-infection [OR = 3.12
(1.89, 5.55); p <0.0001], and unemployment [OR = 1.79
(1.11, 2.93); p = 0.0180] were also significant determi-
nants of death, whereas psychological distress was not
[OR = 1.028 (0.99, 1.07); p = 0.1578 in the initial model).
TB health literacy
Patients with culture-confirmed TB had, at diagnosis, a
similar TB-related health literacy score than those with-
out TB [median (IQR) 7 (4–8) vs. 6 (4–8); p = 0.7880].
In a multivariate analysis (Additional file 1: Table S5),
people who had a lower education level [estimate (95 % CI)
Fig. 2 Correlation between psychological distress (Kessler K-10 score)
and increased morbidity, measured using a TB-symptom score (TBscore)
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Table 2 Unadjusted and adjusted baseline associates of psychological distress (K-10 score) at recruitment






Demographic and clinical characteristics
Age 0.045 (0.010. 0.083) 0.0132 0.031 (−0.003, 0.064) 0.0702
Male −2.499 (−3.371, −1.627) <0.0001 −1.447 (−2.278, −0.617) 0.0007
Previously had TB −0.541 (−1.561, 0.479) 0.2987 0.980 (0.094, 1.866) 0.0304
HIV-infected 3.059 (2.172, 3.946) <0.0001 0.061 (−0.763, 0.885) 0.8844
TBscore 0.698 (0.481, 0.914) <0.0001 1.000 (0.802, 1.199) <0.0001
Allocation arm Xpert MTB/RIF −0.245 (−1.118, 0.628) 0.5824 - -
Culture-confirmed TB −0.450 (−1.468, 0.568) 0.3866 - -
Substance use
Tobacco smoker −3.123 (−4.078, −2.169) <0.0001 - -
Alcohol consumption
Never 1.00 (reference) N/A 1.00 (reference) N/A
Social −3.124 (−4.203, −2.045) <0.0001 −0.599 (−1.592, 0.395) 0.2378
Regular −2.061 (−3.212, −0.910) 0.0005 −0.001 (−1.041, 1.039) 0.9991
Heavy −1.362 (−3.496, 0.773) 0.2115 3.082 (1.256,4.907) 0.0010
Educational characteristics
Educational level
None −6.496 (−10.722, −2.251) 0.0027 −1.667 (−5.155, 1.82) 0.3489
Primary school −3.751 (−7.664, 0.160) 0.0604 0.420 (−2.771, 3.610) 0.7966
Middle school −5.224 (−9.140, −1.308) 0.0090 −0.528 (−3.762, 2.707) 0.7492
High School −4.792 (−8.700, −0.884) 0.0164 −0.324 (−3.508, 2.860) 0.8418
Intermediate or post-high school diploma −3.5906 (−7.674, 0.493) 0.0850 0.988 (−2.378, 4.354) 0.5651
Graduate or post-graduate 0.00 (reference) N/A 0.00 (reference) N/A
TB health literacy score −0.409 (−0.551, −0.267) <0.0001 - -
Economic characteristics
Unemployed or retired 2.877 (2.012, 3.742) <0.0001 - -
Personal monthly income
Tier 1 1.578 (−1.982, 5.139) 0.3850 - -
Tier 2 −1.291 (−4.879, 2.296) 0.4806 - -
Tier 3 −0.804 (−4.637, 3.028) 0.6809 - -
Tier 4 0.00 (reference) N/A - -
Household monthly income
Tier 1 −1.802 (−4.187, 0.583) 0.1389 - -
Tier 2 −2.352 (−4.718, 0.015) 0.0516 - -
Tier 3 −2.066 (−4.676, 0.543) 0.1209 - -
Tier 4 0.00 (reference) N/A - -
Sites
Cape Town 0.565 (−0.637, 1.767) 0.3569 1.525 (0.142, 2.907) 0.0309
Harare 10.648 (9.440, 11.856) <0.0001 11.070 (9.802, 12.340) <0.0001
Lusaka −0.636 (−1.845, 0.574) 0.3031 −1.281 (−2.623, 0.061) 0.0616
Mbeya 8.423 (6.603, 10.243) <0.0001 6.923 (4.9945, 8.911) <0.0001
Durban 0.00 (reference) N/A 0.00 (reference) N/A
Cells marked with a dash indicate variables excluded from the final multivariate model
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Table 3 Unadjusted and adjusted baseline associates of treatment non-adherence in patients with culture-confirmed TB
Univariate analysis Multivariate analysis
Crude odds ratio (95 % CI) P-value Adjusted odds ratio (95 % CI) P-value
Demographic and clinical characteristics
Age 0.997 (0.970, 1.024) 0.8457 0.988 (0.947, 1.029) 0.5563
Male 0.859 (0.491, 1.517) 0.5971 0.895 (0.402, 2.246) 0.8951
Previously had TB 0.729 (0.346, 1.445) 0.3832 - -
HIV-infected 1.227 (0.693, 2.215) 0.4889 1.358 (0.557, 3.421) 0.5054
TBscore 0.868 (0.748, 0.998) 0.0524 0.639 (0.497, 0.797) 0.0001
Allocation arm Xpert MTB/RIF 2.038 (1.161, 3.648) 0.0144 2.174 (0.985, 5.015) 0.05993
K-10 score 1.073 (1.039, 1.112) <0.0001 1.082 (1.033, 1.137) 0.0012
Substance use
Tobacco smoker 0.651 (0.325, 1.239) 0.2055 - -
Alcohol consumption
Never 1.00 (reference) N/A 1.00 (reference) N/A
Social 0.629 (0.296, 1.279) 0.2122 0.505 (0.177, 1.364) 0.1874
Regular 0.701 (0.327, 1.435) 0.3422 0.707 (0.243, 1.986) 0.5137
Heavy 2.371 (0.624, 9.029) 0.1933 14.83 (2.083, 122.9) 0.0090
Educational characteristics
Educational level
None 0.375 (0.030, 4.299) 0.4167 - -
Primary school 0.500 (0.077, 4.022) 0.4668 - -
Middle school 0.330 (0.049, 2.727) 0.2539 - -
High School 0.684 (0.107, 5.428) 0.6874 - -
Intermediate or post-high school diploma 0.789 (0.112, 6.743) 0.81183 - -
Graduate or post-graduate 0.00 (reference) N/A - -
TB health literacy score 0.885 (0.809, 0.967) 0.0071 0.798 (0.696, 0.907) 0.0008
Economic characteristics
Unemployed or retired - -
Personal monthly income
Tier 1 * 0.9839 - -
Tier 2 * 0.9840 - -
Tier 3 * 0.9838 - -
Tier 4 1.00 (reference) N/A - -
Household monthly income
Tier 1 0.353 (0.102, 1.181) 0.089747 0.288 (0.064, 1.264) 0.0997
Tier 2 0.275 (0.082, 0.898) 0.031567 0.350 (0.082, 1.445) 0.1462
Tier 3 0.202 (0.039, 0.900) 0.041743 0.156 (0.024, 0.922) 0.0462
Tier 4 1.00 (reference) N/A 1.00 (reference) N/A
Sites
Cape Town 0.427 (0.121 1.593) 0.1868 - -
Harare 3.709 (1.308, 12.285) 0.01956 - -
Lusaka 1.036 (0.358, 3.461) 0.9499 - -
Mbeya 0.900 (0.193, 3.980) 0.8888 - -
Durban 1.00 (reference) N/A - -
Cells marked with a dash indicate variables excluded from the final multivariate model
*indicates where accurate estimation of the odds ratio failed due to too few observations
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Table 4 Unadjusted and adjusted baseline associates of improvement in TB symptom score (TBscore) in patients started on anti-TB
treatment and followed-up at six months
Univariate analysis Multivariate analysis
Crude estimate (95 % CI) P-value Adjusted estimate (95 % CI) P-value
Demographic and clinical characteristics
Age 0.002 (−0.007, 0.010) 0.7101 −0.013 (−0.022, −0.003) 0.0097
Male 0.357 (0.156, 0.557) 0.0005 0.263 (0.040, 0.486) 0.0208
Previously had TB 0.349 (0.124, 0.574) 0.0024 −0.228 (−0.491, 0.0353) 0.0901
HIV-infected −0.365 (−0.568, −0.162) 0.0005 0.406 (0.163, 0.6493) 0.0011
TBscore 0.212 (0.157, 0.266) <0.0001
Allocation arm Xpert MTB/RIF 0.059 (−0.142, 0.261) 0.5607 - -
Culture-confirmed TB 0.368 (0.128, 0.607) 0.0027 0.587 (0.323, 0.850) <0.0001
K-10 score −0.045 (−0.056, −0.031) <0.0001 0.041 (0.024, 0.057) <0.0001
Substance use
Tobacco smoker 0.340 (0.127, 0.554) 0.0018 - -
Alcohol consumption
Never 0.00 (reference) N/A - -
Social 0.088 (−0.151, 0.327) 0.4722 - -
Regular 0.264 (0.000, 0.527) 0.0501 - -
Heavy 1.346 (0.816, 1.876) <0.0001 - -
Educational characteristics
Educational level
None 1.711 (0.742, 2.679) 0.0006 - -
Primary school 1.075 (0.216, 1.933) 0.0143 - -
Middle school 0.703 (−0.147, 1.552) 0.1052 - -
High School 0.718 (−0.137, 1.572) 0.1002 - -
Intermediate or post-high school diploma 0.404 (−0.492, 1.299) 0.3771 - -
Graduate or post-graduate 0.00 (reference) N/A
TB health literacy score 0.0450 (0.011, 0.079) 0.0102 - -
Economic characteristics
Unemployed or retired −0.087 (−0.293, 0.120) 0.4105 - -
Personal monthly income
Tier 1 0.271 (−0.578, 1.119) 0.53181 - -
Tier 2 0.354 (−0.503, 1.211) 0.4180 - -
Tier 3 −0.066 (−0.977, 0.846) 0.8879 - -
Tier 4 0.00 (reference) N/A - -
Household monthly income
Tier 1 0.948 (0.427, 1.469) 0.0004 - -
Tier 2 0.749 (0.230, 1.269) 0.0048 - -
Tier 3 0.282 (−0.292, 0.855) 0.3360 - -
Tier 4 0.00 (reference) N/A - -
Sites - -
Cape Town 0.322 (0.060, 0.585) 0.01635 −1.306 (−1.691, −0.921) <0.0001
Harare −0.926 (−1.198, −0.655) <0.0001 −0.471 (−0.883, −0.059) 0.0253
Lusaka 2.415 (2.091, 2.740) <0.0001 −2.393 (−2.822, −1.965) <0.0001
Mbeya 0.5904 (0.202, 0.979) 0.0030 0.367 (−0.226, 0.960) 0.2259
Durban 0.00 (reference) N/A 0.00 (reference) N/A
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of −4.30 (−5.81, −2.78) and p <0.0001 for those who had
no formal education] and said they consumed alcohol
socially [estimate = −0.54 (−0.97, −0.10); p = 0.0159]
had a lower literacy score. Previous TB was associated
with increased TB health literacy [estimate = 0.43 (0.04,
0.82); p = 0.0301] in the model.
Cough duration
Patients with TB who reported themselves to have been
coughing for at least two weeks prior to presenting to the
clinic (n = 1402) (and are hence likely to have transmitted
more disease than those who had not) experienced a delay
in seeking care. These patients had higher psychological
distress than those who had not had a cough for at least
two weeks (n = 100) [K-10 score of 22 (15–29) vs. 13
(11.75-17.25); p = 0.0002)]. However, in a multivariable
model for cough duration restricted to patients in the
former group, HIV-infection [estimate = −14.85
(−27.87, −1.838); p = 0.0267], and heavy alcohol usage
[estimate = 85.14 (44.77, 125.5); p <0.0001] were the
only significant associates of cough duration (Additional
file 1: Table S6).
Employment
In Mbeya and Durban, the proportion of patients who
were unemployed was greater amongst those with
culture-confirmed TB compared to those with without
TB [69 % vs. 37 % for Mbeya (p = 0.0059); 66 % vs. 39 %
for Durban (p = 0.0045)], however, this proportion did not
differ significantly at the other sites. Amongst patients
who were unemployed, 23 % (184/797) said their
unemployment was due to their current illness. When
psychological distress at recruitment was compared be-
tween patients who later reported at follow-up that their
illness had, since diagnosis, affected their employment and
those who had reported it had not, baseline K-10 scores
were elevated amongst the former group [22 (16–30) vs.
19 (14–24); p = 0.0013], however, when multivariable
adjustments were performed (Additional file 1: Table S7),
K-10 score was not an independent predictor of this out-
come [OR = 1.02 (0.978-1.064); p = 0.3465].
Discussion
This large multicentre study examined the relationship
of psychological distress, alcohol use, health literacy,
clinical morbidity, and socioeconomic factors, with treat-
ment non-adherence and clinical outcomes. Our key
findings were that: (i) heavy alcohol usage, female gen-
der, increased morbidity, and previous TB are associated
with increased levels of psychological distress amongst
patients with symptoms of TB, however, TB status is
not; (ii) increased psychological distress, heavy alcohol
usage, decreased health literacy and decreased morbidity
are independently associated with non-adherence to
treatment; (iii) patients who were more psychologically
distressed at treatment initiation had the greatest clinical
improvement in symptoms, provided they were adher-
ent; and (iv) HIV-infection and heavy alcohol usage are
associated with a delay in seeking care (defined as dur-
ation of coughing before presentation) amongst patients
with culture-confirmed TB.
We found that for every point increase in K-10 score,
there was an 8 % increase in the odds of treatment non-
adherence over a six month period, after adjustment for
site-specific interactions (provided other factors
remained equal). Furthermore, for each one unit in-
crease in TB health literacy score, there was a 20 % re-
duction in the relative risk of treatment non-adherence.
This suggests that education about TB at the time of
treatment initiation is presently inadequate, and that this
results in non-adherence. Although rates of psycho-
logical distress have previously been surveyed in patients
seeking care for TB [14, 33] and HIV [34], our study is,
to the best of our knowledge, the first to demonstrate a
link between psychological distress and anti-TB treatment
non-adherence, and the first to show that poor level of
TB-related health literacy, which we show is itself associ-
ated with a low level of formal education, is a risk factor
for non-adherence. A study from Peru [19] has previously
demonstrated an association between major depressive ep-
isodes and cocaine use with a composite outcome com-
prised of anti-TB treatment abandonment, however, this
study did not examine non-adherence specifically.
Our study showed approximately half of patients pre-
senting to our primary care TB clinics in Harare and
Mbeya to have a severe level (K-10 ≥ 30) of psychological
distress, similar to that previous reported amongst
Ethiopian patients infected with HIV or TB or both
[33]. These high levels of psychological distress likely
resulted from the high local prevalence of risk factors. For
example, Harare had the highest rate of HIV-infection out
of the five sites, whereas more patients in Mbeya reported
themselves to consume alcohol regularly than at any other
site. In South Africa, the rate of severe psychological dis-
tress detected is identical (8 %) to that reported in an
earlier nationally-representative survey of mental illness
[32]. To the best of our knowledge, our study is the first
to report the use of the K-10 questionnaire in Southern
African countries besides South Africa.
We found women and patients living with HIV to
have a significantly higher level of psychological distress
than men or HIV-uninfected patients, respectively. Ac-
cording to stratifications of the K-10 score previously
performed in South Africa (where a score of 20–24 was
graded as moderate) [32], these differences, although
significant, would not constitute an overall increase in
risk classification level. We found heavy alcohol use to
be associated with increased psychological distress and,
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as demonstrated by others [9, 35, 36], to be associated
with non-adherence. Heavy alcohol users are more
likely to experience social marginalisation and have side
effects from their anti-TB medication [5], which may
further worsen non-adherence. These data suggest that
screening for common mental disorders and alcohol
abuse should, together with measures to educate pa-
tients about TB, be strengthened. Education and
counselling to promote adherence can be effective
[37] and our data suggest they should be targeted at
high risk individuals who drink alcohol heavily, have
severe psychological distress, and have low TB health
literacy. Of note in this study, is the strong, bidirec-
tional linkage between clinical signs and symptoms
and psychological distress.
We found HIV-infection and heavy alcohol usage to
be associated with a longer duration of cough before
in presentation to the clinic, which is suggestive that
these patients may be responsible for more transmis-
sion than those who present earlier. This is likely ex-
acerbated by the tendency of patients who are heavy
users of alcohol to congregate in settings permissive
for transmission [5]. Both alcohol use and HIV have
previously been described to be associated with a
delay in seeking care [38, 39], and our study reiterates
the need for active case finding targeted at these
individuals.
Our study has limitations. Firstly, we reviewed DOTS
treatment cards, and thus patients who visited the clinic
but did not take their medication may have been missed.
This method is, however, widely used for research [40–
42], as it is practical and cost effective, especially com-
pared to methods that require monitoring drug concen-
trations. We also only recorded whether patients were
compliant, but did not capture data about the propor-
tion of doses taken. Consequently, we were unable to
discriminate between patients who only missed a few
doses and those who were completely non-compliant
and had defaulted (which is defined as no treatment for
a continuous period of two months by the World Health
Organisation [43]). Secondly, we measured psycho-
logical distress once-off on a cross-sectional basis, when
ideally it should be measured longitudinally over the
course of treatment, however, we wanted to know if in-
terventions at diagnosis (which is when the longest
patient-health system encounter occurs) could be effect-
ive. Thirdly, the parent study was a randomised controlled
trial of a diagnostic test, however, in none of our multivari-
able analyses was allocation arm a significant associate of
model outcome. Fourthly, we did not use a standard
measure of alcohol consumption severity, such as AUDIT
[44]. Finally, our study was not an interventional study to
measure the impact of counselling for reducing non-
adherence.
Conclusions
Overall, our study found severe psychological distress to
be frequent amongst patients seeking care for TB in
Southern Africa. We found a clear linkage between psy-
chological distress, alcohol use, health literacy, and
clinical morbidity with non-adherence to anti-TB treat-
ment, which was independent of socioeconomic factors
and site-specific interactions. Psychological distress was
strongly co-associated with clinical signs and symptoms.
Screening for psychological distress could, together with
counselling to reduce alcohol consumption and improve
patients’ knowledge about TB, reduce treatment non-
adherence.
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